Hence, small molecules targeting circadian clock regulators that may possess immune-modulatory properties in addition to pro-myogenic actions could be developed to promote regenerative capacity while alleviating chronic inflammation in DMD, which may yield robust efficacy in ameliorating muscular dystrophy. This evidence concerns the gene CLOCK and Duchenne muscular dystrophy.